Clevecord Market Report 2026

Clevecord Market Overview

• The Clevecord market growth in the historic period has been driven by limited availability of matched donors, early success of cord blood transplants • Market expansion is supported by expansion of stem cell therapy applications, improved transplant outcomes • Growth Driver: Rising Demand For Stem Cell Therapies Driving Clevecord Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Clevecord Market?

Clevecord is a stem cell product derived from umbilical cord blood, used primarily in hematopoietic stem cell transplantation. It is designed for patients with hematopoietic system disorders such as leukemia or lymphoma, particularly when a suitable unrelated donor is available. The product contains hematopoietic progenitor cells that are critical for blood and immune system recovery after aggressive treatments like chemotherapy. The main types of indications for clevecord include chronic myeloid leukemia (cml) and gastrointestinal stromal tumors (gists). Chronic myeloid leukemia (CML) is a type of cancer that originates in the bone marrow and affects the blood, characterized by the uncontrolled growth of white blood cells. It is distributed through various channels such as hospital pharmacies, retail pharmacies, and specialty pharmacies and is used by hospitals, clinics, ambulatory care, and home care.

What Is The Clevecord Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of stem cell therapy applications, improved transplant outcomes, growth of cord blood registries, increasing oncology treatment demand, supportive regulatory frameworks. Major trends in the forecast period include growing use of cord blood stem cell transplants, rising demand for alternative donor sources, expansion of hematopoietic transplant indications, increasing adoption in pediatric and adult oncology, strengthening cord blood banking infrastructure.

Global Clevecord Market Segmentation

1) By Indication: Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GISTs) 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies 3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

What Are The Drivers Of The Clevecord Market?

The rise in demand for stem cell therapies is expected to accelerate the growth of the clevecord market going forward. Stem cell therapy is a medical treatment that involves the use of stem cells to repair or replace damaged tissues or cells to treat various conditions such as blood disorders, neurodegenerative diseases, and injuries. Demand for stem cell therapies is rising due to factors such as advancements in regenerative medicine, the growth of personalized medicine, heightened public awareness, and improvements in technology. Clevecord is utilized in stem cell therapies for its rich mesenchymal stem cell content, supporting tissue regeneration, immune modulation, and advanced therapeutic applications. For instance, in January 2024, according to the Bioindustry Association (BIA), a UK-based trade association for life sciences and the biotech industry, the UK remains the leading hub for clinical trials in cell and gene therapy in Europe as of October 2023, with 84 drugs in development, outpacing France (45), Spain (44), and Germany (40). On a global scale, US companies secured 86% of venture funding for cell and gene therapy in 2022 and are poised to continue leading in 2023. Therefore, the rise in demand for stem cell therapies is driving the growth of the clevecord industry. The rising healthcare expenditure is expected to propel the growth of the clevecord market going forward. Healthcare expenditure refers to the total amount of resources spent on healthcare services, products, and related activities, including prevention, diagnosis, treatment, and management of health conditions. Healthcare expenditure is rising due to factors such as an aging population, advancements in medical technology, increasing prevalence of chronic diseases, and higher costs of pharmaceuticals and medical services. Healthcare expenditure in cleveCord drives advancements in cord blood banking, supporting innovative medical therapies and ensuring accessible, high-quality stem cell storage solutions. For instance, in April 2025, according to the Office for National Statistics (ONS), a UK-based independent producer of official statistics, total healthcare expenditure rose by 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024, while healthcare’s share of GDP held steady at 11.1% in 2024, matching the previous year. Therefore, the rising healthcare expenditure is driving the growth of the clevecord industry. The increasing global aging population is expected to boost the growth of the clevecord market going forward. The aging population refers to a demographic group characterized by a higher proportion of individuals aged 65 and older, often due to increased life expectancy and declining birth rates. The aging population is increasing due to advancements in healthcare and living standards that extend life expectancy, combined with declining birth rates in many regions. The aging population requires clevecord, as stem cell therapies using hematopoietic progenitor cells from cord blood can help treat age-related blood disorders, cancers, and degenerative diseases, offering potential regenerative solutions for older individuals with weakened immune systems and reduced cell regeneration capacity. For instance, in October 2025, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, by 2030, one in six people globally will be aged 60 or older, with the population of individuals in this age group projected to double to 2.1 billion by 2050. Therefore, the increasing global aging population is driving the growth of the clevecord industry.

Key Players In The Global Clevecord Market

Major companies operating in the clevecord market are Cleveland Cord Blood Center Inc.

Regional Insights

North America was the largest region in the clevecord market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Clevecord Market?

The clevecord market consists of sales of ex vivo stem cell expansion kits, hematopoietic stem cell products, stem cell-derived wound healing products and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clevecord Market Report 2026?

The clevecord market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clevecord industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.